Drug Shortage Report for CERETEC

Last updated on 2024-09-25 History
Report ID 238131
Drug Identification Number 02329034
Brand name CERETEC
Common or Proper name Kit for the Preparation of Technetium-99m Exametazime Injection
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) EXAMETAZIME
Strength(s) 0.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5 vial kit
ATC code V09HA
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-09-23
Actual start date
Estimated end date 2024-09-27
Actual end date 2024-09-24
Shortage status Resolved
Updated date 2024-09-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@gehealthcare.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-09-25 French Compare
v4 2024-09-25 English Compare
v3 2024-09-24 English Compare
v2 2024-09-20 French Compare
v1 2024-09-20 English Compare

Showing 1 to 5 of 5